The cytochromes P450 (CYP) response to allergic inflammation of the lung

Ivaylo Stoilov1, Winfried Krueger, Dayna Mankowski

  • 1Department of Pharmacology, University of Connecticut Health Center, Farmington, CT 06030, USA. ivo@neuron.uchc.edu

Insights

This study reveals how the mouse Cytochrome P450 (Cyp) gene family responds to allergic airway disease. Cyp gene expression changes during inflammation and resolution, suggesting a role in metabolic regulation during allergic responses.

Area of Science:

  • Immunology
  • Pharmacology
  • Molecular Biology

Background:

  • Allergic airway diseases involve complex inflammatory responses.
  • The Cytochrome P450 (Cyp) gene family plays a role in metabolizing various compounds.

Purpose of the Study:

  • To investigate the expression patterns of the mouse Cyp gene family during ovalbumin (OVA)-induced allergic airway disease.
  • To understand the correlation between Cyp gene expression and the inflammatory process.

Main Methods:

  • Ovalbumin (OVA)-induced allergic airway disease model in mice.
  • Quantitative analysis of mRNA levels for inflammatory mediators (IL-4, IL-13, Ccl11, Ccl20) and Cyp genes.
  • Monitoring gene expression during acute inflammation and resolution phases.

Main Results:

  • Inflammatory mediators IL-4, IL-13, and Ccl11 increased during acute inflammation and decreased upon resolution.
  • Ccl20 expression was elevated during the resolution phase.
  • Differential regulation of Cyp gene family members was observed, with some decreasing (e.g., Cyp2e1, Cyp2f2) and others increasing (e.g., Cyp4f18, Cyp5a1) during acute inflammation, returning to normal upon resolution.

Conclusions:

  • The Cyp gene family exhibits distinct expression changes in response to allergic airway inflammation.
  • These alterations suggest a potential role for Cyp enzymes in modulating the metabolism of endogenous compounds and xenobiotics during allergic responses.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...